Shopping Cart
- Remove All
- Your shopping cart is currently empty
Macimorelin Acetate (EP-1572), an orally active growth hormone (GH) secretagogue and a ghrelin receptor (GHSR) agonist, stimulates GH release. It is utilized in research focusing on adult growth hormone deficiency (AGHD) and Cancer Anorexia-Cachexia Syndrome (CACS).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | 501 € | 8-10 weeks | |
50 mg | 806 € | 8-10 weeks | |
100 mg | 1.290 € | 8-10 weeks |
Description | Macimorelin Acetate (EP-1572), an orally active growth hormone (GH) secretagogue and a ghrelin receptor (GHSR) agonist, stimulates GH release. It is utilized in research focusing on adult growth hormone deficiency (AGHD) and Cancer Anorexia-Cachexia Syndrome (CACS). |
In vitro | NFATc1-IN-1 (0、0.5、1.0、1.5、2.0、2.5 μM, 4 days) exhibits potent inhibitory activities on osteoclast formation and function, which eventually translates into decreased bone resorption while showing no cytotoxic effects towards osteoclast precursor cells at concentrations of as high as 2.5 μM.[1] NFATc1-IN-1 (1.5-2.5 μM, 24 h) blocks NFATc1 nuclear translocation and decreases the level of NFATc1.[1] |
Alias | EP-1572 acetate ; AEZS-130 acetate, EP-1572 acetate, AEZS-130 acetate |
Molecular Weight | 534.61 |
Formula | C28H34N6O5 |
Cas No. | 945212-59-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.